Machine learning based development of an early diagnosis signature for distinguishing hospitalized pediatric human respiratory syncytial virus infection from mycoplasma pneumonia - Report - MDSpire

Machine learning based development of an early diagnosis signature for distinguishing hospitalized pediatric human respiratory syncytial virus infection from mycoplasma pneumonia

  • By

  • Xiandan Chen

  • Linlu Ying

  • Weixing Kong

  • Wangxiong Hu

  • Zhong Hu

  • June 2, 2026

  • 0 min

Share

Clinical Report: Development of a Blood-Based Biomarker Signature Using Machine Learning

Overview

{'AUC-ROC': '0.89 (95% CI: 0.85–0.90)'}

Background

{'remove': 'highlighting the need for innovative approaches such as blood-based biomarker signatures.'}

Data Highlights

BiomarkerRole
Eosinophilic granulocytePart of the five-biomarker signature
Immunoglobulin APart of the five-biomarker signature
Lactic dehydrogenase (LDH)Part of the five-biomarker signature
β2-microglobulinPart of the five-biomarker signature
Albumin to globulin ratio (AGR)Part of the five-biomarker signature

Key Findings

{'remove': 'The study highlights the potential for a minimally invasive diagnostic tool in pediatric CAP.'}

Clinical Implications

{'remove': 'The developed biomarker signature may assist clinicians in rapidly distinguishing between HRSV and MP infections, potentially improving treatment decisions and patient management.'}

Conclusion

{'remove': 'This study presents a promising blood-based biomarker signature for differentiating HRSV from MP infections in pediatric patients, warranting further research to confirm its effectiveness in clinical settings.'}

Related Resources & Content

  1. The Journal of Infectious Diseases, 2023 -- Transcriptomic Biomarkers Associated With Microbiological Etiology and Disease Severity in Childhood Pneumonia
  2. Frontiers in Pediatrics, 2026 -- Identification of clinical phenotypes and prediction model for the mixed-infection phenotype of pediatric community-acquired pneumonia based on unsupervised machine learning
  3. Frontiers in Pediatrics, 2026 -- Machine learning-based identification of inflammatory biomarkers for predicting pulmonary consolidation in children with Chlamydia pneumoniae infection
  4. The Journal of Infectious Diseases, 2023 -- Real-World Application of the MeMed BV Test in Differentiating Bacterial, Viral, and Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia
  5. Infectious Diseases Society of America, 2026 -- Management of Community-Acquired Pneumonia in Infants and Children
  6. CDC RSV Hospitalization Surveillance Network
  7. https://www.idsociety.org/globalassets/idsa/practice-guidelines/cap-2026/the-management-of-community-acquired-pneumonia-in-infants-and-children-older-than-3-months-of-age-topic-manuscript-2.25.26.pdf
  8. A 5-transcript signature for discriminating viral and bacterial etiology in pediatric pneumonia - ScienceDirect

Original Source(s)

Machine learning based development of an early diagnosis signature for distinguishing hospitalized pediatric human respiratory syncytial virus infection from mycoplasma pneumonia

  • by Xiandan Chen, Linlu Ying, Weixing Kong, Wangxiong Hu, Zhong Hu

  • June 2, 2026

Related Content

What Parents Need to Know About Screen Time and Language Development

FDA Approves Ensitrelvir to Prevent COVID-19 After Exposure

Phase 3 data showed a 67% reduction in symptomatic infection among exposed household contacts who tested negative at baseline.

Celiac Tied to Higher Transplant Rate

Liver transplantation showed the strongest association, although absolute event rates remained low in a nationwide Swedish cohort study.